Dostarlimab 50 mg/ml sol. Inj. Frs. 10 ml IV
Deadline:N/A
Tender information
Portugal
Type
Contract award
Procedure
Restricted procedure
Dostarlimab 50 mg/ml sol. Inj. Frs. 10 ml IV
DOSTARLIMAB 50 MG/ML SOL. INJ. FRS 10 ML IV
DOSTARLIMAB 50 MG/ML SOL. INJ. FRS 10 ML IV
Buyer
Instituto Português de Oncologia do Porto Francisco Gentil, EPE
Contract award
Documents
Contract award
Buyer
Instituto Português de Oncologia do Porto Francisco Gentil, EPE
Contract awarded
Important dates
1 Jun - Publication date
Unlock Full Access with Mercell Bidding Business Plus